Response Assessment and Prediction of Progression-Free Survival by <sup>68</sup>Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Fadi,Khreish ^[1] ; Mona,Wiessner ^[1] ; Florian,Rosar ^[1] ; Zaidoon,Ghazal ^[1] ; Amir,Sabet ^[2] ; Stephan,Maus ^[1] ; Johannes,Linxweiler ^[3] ; Mark,Bartholomä ^[1] ; Samer,Ezziddin ^[1]

作者单位： Department of Nuclear Medicine, Saarland University, 66421 Homburg, Germany. ^[1] Department of Nuclear Medicine, Frankfurt University, 60590 Frankfurt am Main, Germany. ^[2] Department of Urology, Saarland University, 66421 Homburg, Germany. ^[3]

关键词 68Ga-PSMA-11 PET/CT Lutetium-177 PSMA-617 metastatic castration-resistant prostate cancer (mCRPC)molecular imaging-based response assessment radioligand therapy tumor-to-liver ratio (TLR)

主题词老年人(Aged);老年人, 80以上(Aged, 80 and over);随访研究(Follow-Up Studies);镓同位素(Gallium Isotopes);镓放射性同位素(Gallium Radioisotopes);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肝(Liver);镥(Lutetium);男(雄)性(Male);中年人(Middle Aged);分子显像(Molecular Imaging);肿瘤转移(Neoplasm Metastasis);前列腺特异抗原(Prostate-Specific Antigen);放射性药物(Radiopharmaceuticals);放射疗法(Radiotherapy);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)

DOI 10.3390/biom11081099

PMID 34439768

发布时间 2021-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomolecules

2021年11卷8期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Response Assessment and Prediction of Progression-Free Survival by <sup>68</sup>Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy.

Biomolecules

相似文献

Biomolecules

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Response Assessment and Prediction of Progression-Free Survival by <sup>68</sup>Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy.

Biomolecules

相似文献

Biomolecules

相关期刊

检索历史清除